Related Topics

Non-Therapeutic Protocol

TRIALS: Transfusional Iron Overload Among Leukemia Survivors

Type of Protocol/Clinical Study

Associated Hematology Studies : Iron overload in leukemia survivors


Red cell transfusions are an important part of supportive cancer therapy. The iron in the transfused blood may build up in the body since the body has no way to get rid of extra iron. Iron tends to build up in the liver and the heart muscle. It is unknown if iron build-up is present many years after completing cancer therapy. It is also not known if extra iron causes harm to internal organs. Doctors want to understand if iron build-up (called “iron overload”) exists in survivors of leukemia. They also want to know if iron overload can cause injury to organs if it is present.


Eligibility criteria, among others, include

Inclusion Criteria

Exclusion Criteria

Principal Investigator

Jane S. Hankins, MD, MS

The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.